首页|超声引导下小剂量复方倍他米松注射对肩袖损伤患者肩关节功能的影响及危险因素分析

超声引导下小剂量复方倍他米松注射对肩袖损伤患者肩关节功能的影响及危险因素分析

Efficacy and risk factors of ultrasound-guided low-dose compound betamethasone injection on shoulder joint function in patients with rotator cuff injury

扫码查看
目的 探究超声引导下小剂量复方倍他米松注射对肩袖损伤患者肩关节功能的改善效果,并分析影响其疗效的因素,旨在为临床提升肩袖损伤患者治疗效果提供帮助.方法 回顾性选择2022年1月—2023年3月于东阳市人民医院接受治疗的96例肩袖损伤患者作为研究对象.患者均接受超声引导下注射小剂量复方倍他米松治疗.比较患者不同时点疼痛水平,治疗前及治疗1个月时肩关节功能、上肢运动能力、日常生活能力.根据治疗1个月时Neer肩关节功能评分评估患者临床疗效,根据评分分为优良组、中差组.统计患者基线资料,采用二元logistic回归分析影响肩袖损伤患者超声引导下小剂量复方倍他米松注射治疗后临床疗效的因素.结果 治疗1个月时,经Neer评分评估,优良率为80.21%(77/96).治疗1个月时患者Neer评分高于治疗前(P<0.05);治疗后1 h、l周、1个月时VAS评分均低于治疗前(P<0.05);治疗1个月时患者上肢Fugl-Meyer功能评分、Barthel指数评分均高于治疗前(P<0.05);治疗1个月时,患者肩关节主动关节活动度均高于治疗前(P<0.05);二元logistic回归分析结果显示,年龄≥60岁、劳动强度为Ⅲ~Ⅳ级、合并糖尿病均是影响肩袖损伤患者临床疗效的危险因素(OR>1,P<0.05).结论 超声引导下注射小剂量倍他米松能够有效改善肩袖损伤患者肩关节功能,提升患者上肢运动及日常生活能力,同时年龄、劳动强度、合并糖尿病与患者临床疗效密切相关.
Objective To explore the effect of ultrasound-guided low-dose compound betamethasone injection on shoulder joint function in patients with rotator cuff injuries,and to analyze the factors affecting its efficacy,to provide help for clin-ical improvement of the therapeutic effect of patients with rotator cuff injury.Methods A retrospective study was con-ducted to select the clinical data of 96 patients with rotator cuff injuries who were treated in Dongyang People's Hospital from January 2022 to March 2023 as the study subjects.All patients were treated with an ultrasound-guided injection of low-dose betamethasone combined with ropivacaine.The pain level at different time points,shoulder joint function,upper limb motor ability,and daily living ability before treatment and 1 month after treatment were compared.The clinical effi-cacy of the patients was evaluated according to the Neer shoulder function score at 1 month of treatment.According to the score,the patients were divided into an excellent group and a poor group.The baseline data of patients were statistically analyzed,and binary logistic regression analysis was used to analyze the factors affecting the clinical efficacy of ultra-sound-guided low-dose hormone injection in patients with rotator cuff injury.Results After 1 month of treatment,the excellent and good rate was 80.21%(77/96)evaluated by Neer score.The Neer scores at 1 month of treatment were higher than those before treatment(P<O.05).The VAS scores at 1 hour,1 week,and 1 month after treatment were low-er than those before treatment and showed a downward trend(P<0.05).The upper limb Fugl-Meyer functional score and Barthel index score of the patients at 1 month after treatment were higher than those before treatment(P<0.05).At 1 month of treatment,the active range of motion of shoulder joint mobility was higher than that before treatment(P<0.05).The results of binary logistic regression analysis showed that age ≥ 60 years old,labor intensity of grade Ⅲ-Ⅳ,and dia-betes mellitus were risk factors affecting the clinical efficacy of patients with rotator cuff injury(OR>1,P<0.05).Conclusion Ultrasound-guided injections of low-dose betamethasone combined with ropivacaine can effectively improve shoulder joint function,upper limb movement,and daily living ability of patients with rotator cuff injuries.At the same time,age,labor intensity,and diabetes are closely related to the clinical efficacy of patients.

Rotator cuff injuryBetamethasoneUltrasound guidanceShoulder joint functionRisk factors

徐琼、吴单、杜信、田涛涛、张茂良、杜奋飞

展开 >

东阳市人民医院康复科,浙江东阳 322100

肩袖损伤 倍他米松 超声引导 肩关节功能 危险因素

浙江省医药卫生科技计划

2022ZH065

2024

中华全科医学
中华预防医学会,安徽省全科医学会

中华全科医学

CSTPCD
影响因子:1.688
ISSN:1674-4152
年,卷(期):2024.22(3)
  • 19